 SAN FRANCISCO , April 22, 2022 PRNewswire -- Nektar Therapeutics NASDAQ:NKTR will host an analyst and investor conference call with Nektar executives on Monday, April 25, 2022, at 2:00 p.m. Pacific Standard Time PST, to outline a new strategic plan for the company and provide updates for the companys research and development pipeline. 